2023 Was a tough year to the biopharma industry, with many providers downsizing and restructuring their workforces to remain afloat. You'll find signs of Restoration, as mergers and acquisitions picked up through the pharmaceutical and everyday living sciences industry in the latter part of 2023 and possess continued their upswing https://sites.google.com/view/bio-sites/blog